Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
565 pages
2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
620 pages
Cancer Monoclonal Antibodies Market to 2015
US$ 1,500.00
Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In...
February 2012
105 pages
Emerging Opportunities in Cancer Nucleic Acid Testing
US$ 1,160.00
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing NAT technologies and products for cancer testing. Contains 45 pages
February 2012
45 pages
Future Italian Tumor Marker Testing Market Outlook
US$ 4,320.00
... Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key ... volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated ...
February 2012
570 pages
Future Cancer Diagnostic Technologies and Market Applications
US$ 1,480.00
... , immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages
December 2011
110 pages
World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition, The
US$ 3,500.00
... Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition - focuses on several segments for cancer treatment including: ... complete research effort into the oncology treatments market in the past ten years, provides market size information for the various types of ...
October 2011
245 pages
Cancer Therapies: Market Research Report
US$ 4,500.00
... report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. ... 2017. A six-year historic analysis is also provided for these markets. The report profiles 152 companies including many key and ...
October 2011
897 pages
Looking at the Cancer Therapy Market
US$ 200.00
... presents a comprehensive research report – Looking at the Cancer Therapy Market – which analyzes the global cancer market. Explaining the basics of cancer, to the treatments available and ...
June 2011
60 pages
US Oncologist Survey: Optimizing Treatment for Advanced Lung Cancer
US$ 1,200.00
... to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment ... with adenocarcinoma Former light smoker whose cancer is EGFR positive Treatment decisions for advanced stages of cancer are difficult to track as information ...
April 2011
56 pages
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists' Survey
US$ 500.00
... for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors ... are missing, directly from high-prescribing US oncologists on the treatment of patients with advanced prostate cancer. Treatment decisions for advanced stages ...
March 2011
24 pages
US Oncologist Survey: Optimizing Treatment for Advanced Prostate Cancer
US$ 1,200.00
... that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open ... , barriers to optimal care, and confidence in treatment. Patients include: Patient case scenarios that progressively unfold, presented to 154 oncologists in a survey for ...
March 2011
52 pages
Competitor Analysis: Cancer Antibodies in Early Clinical Development
US$ 1,210.00
... CD20, VEGF and Her2, but also of many new and unique antibodies directed against novel targets which will have to show its ... cancer. In addition, the report lists company-specific R&D pipelines of anti-cancer antibodies. Competitor projects are listed in a tabular format providing information on: Drug Codes, ...
February 2011
183 pages
Oncologist Survey: Optimizing Treatment for Advanced Renal Cell Cancer
US$ 500.00
Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening ...
February 2011
59 pages
US Oncologist Survey: Optimizing Treatment for Metastatic Breast Cancer
US$ 1,200.00
Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening at ...
January 2011
59 pages
Triple Positive Metastatic Breast Cancer: Clinical Insights from a US Oncologists Survey
US$ 500.00
... the report, presented to 174 high-prescribing oncologists on Triple Positive Metastatic Breast Cancer for their open responses on clinical decisions. Patient ... the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions. ...
January 2011
30 pages
Bladder Cancer Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, ... many key and niche players such as Affitech A/S, Allergan, Inc., Allos Therapeutics, Inc., Astellas Pharma, Inc., Astrazeneca Plc, AVI BioPharma, Inc., ...
October 2010
580 pages
Bladder Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Bladder Cancer Therapy Area Pipeline Report contains detailed information on the bladder cancer drug pipeline. This report provides insight into the pipeline status of bladder...
September 2010
141 pages
Breast Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Breast Cancer Therapy Area Pipeline Report contains detailed information on the breast cancer drug pipeline. This report provides insight into the pipeline status of breast ca...
September 2010
1178 pages
Cervical Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Cervical Cancer Therapy Area Pipeline Report contains detailed information on the cervical cancer drug pipeline. This report provides insight into the pipeline status of cervi...
September 2010
120 pages
Colorectal and Colon Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Colorectal and Colon Cancer Therapy Area Pipeline Report contains detailed information on the colorectal and colon cancer drug pipeline. This report provides insight into the...
September 2010
957 pages
Head and Neck Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Head and Neck Cancer Therapy Area Pipeline Report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline statu...
September 2010
423 pages
Kidney Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Kidney Cancer Therapy Area Pipeline Report contains detailed information on the kidney cancer drug pipeline. This report provides insight into the pipeline status of kidney ca...
September 2010
431 pages
Liver Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Liver Cancer Therapy Area Pipeline Report contains detailed information on the liver cancer drug pipeline. This report provides insight into the pipeline status of liver cance...
September 2010
419 pages
Ovarian Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the ovarian cancer drug pipeline. This report provides insight into the pipeline status of ovarian...
September 2010
589 pages
Pancreatic Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Pancreatic Cancer Therapy Area Pipeline Report contains detailed information on the pancreatic cancer drug pipeline. This report provides insight into the pipeline status of p...
September 2010
403 pages
Prostate Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Prostate Cancer Therapy Area Pipeline Report contains detailed information on the prostate cancer drug pipeline. This report provides insight into the pipeline status of prost...
September 2010
847 pages
Skin Cancer and Melanoma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Skin Cancer and Melanoma Therapy Area Pipeline Report contains detailed information on the skin cancer and melanoma drug pipeline. This report provides insight into the pipeli...
September 2010
550 pages
Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025
US$ 2,325.00
... informed opinion to benefit your work. Why you should buy Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 This report gives ... our survey. This report is essential reading for anybody interested in the cancer drug industry and market. With expanding patient populations and unmet ...
June 2010
107 pages
Cancer Bladder Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Bladder Cancer Therapy Area Pipeline Report contains detailed information on the bladder cancer drug pipeline. This report provides insight into the pipeline status of bladder...
January 2010
138 pages
Cancer Brain Tumor Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Brain Tumor Therapy Area Pipeline Report contains detailed information on the brain tumor drug pipeline. This report provides insight into the pipeline status of brain tumor d...
January 2010
373 pages
Cancer Breast Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Breast Cancer Therapy Area Pipeline Report contains detailed information on the breast cancer drug pipeline. This report provides insight into the pipeline status of breast ca...
January 2010
1119 pages
Cancer Head and Neck Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Head and Neck Cancer Therapy Area Pipeline Report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline statu...
January 2010
406 pages
Cancer Kidney Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Kidney Cancer Therapy Area Pipeline Report contains detailed information on the kidney cancer drug pipeline. This report provides insight into the pipeline status of kidney ca...
January 2010
391 pages